ZHENGLUN ZHU, M.D.
Medical Practice at Francis St, Boston, MA
License number
Massachusetts 154768
Category
Medical Practice
Type
Specialist
Address
Address
2
75 Francis St, Boston, MA 02115
111 Cypress St, Brookline, MA 02445
111 Cypress St, Brookline, MA 02445
Phone
(617) 732-5467
(617) 730-5807 (Fax)
(857) 307-0896
(617) 730-5807 (Fax)
(857) 307-0896
Personal information
See more information about ZHENGLUN ZHU at radaris.comName
Address
Phone
500 Washington St, Quincy, MA 02169
150 Quarry St, Quincy, MA 02169
77 Pond Ave, Brookline, MA 02445
85 Brainerd Rd, Allston, MA 02134
Organization information
See more information about ZHENGLUN ZHU at bizstanding.comZhenglun Zhu MD
75 Francis St, Boston, MA 02115
Industry:
Internist
Phone:
(617) 732-5467 (Phone)
Zhenglun '' Zhu
Professional information
Dr. Zhenglun Zhu, Boston MA - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
75 Francis St, Boston 02115
(617) 732-5467 (Phone), (617) 730-5807 (Fax)
(617) 732-5467 (Phone), (617) 730-5807 (Fax)
Certifications:
Gastroenterology, 2003, Internal Medicine, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Zhenglun Zhu, Boston MA
Specialties:
Gastroenterology, Medical Oncology
Work:
Brigham and Women's Hospital
75 Francis St, Boston, MA 02115
75 Francis St, Boston, MA 02115
Education:
Beijing School Of Medicine (1988)
Treatment Of Cellular Proliferative Disorders With Compositions Comprising Hom Polypeptide (Also Known As Xom, Ventx2)
US Patent:
7994126, Aug 9, 2011
Filed:
Feb 22, 2007
Appl. No.:
11/677828
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
A61K 38/00
US Classification:
514 79
Abstract:
Disclosed are compositions comprising Hom polypeptide (also known as Xom, Ventx2) and methods for treating cellular proliferative disorders comprising. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.
Genetically Engineered Cell Lines And Systems For Propagating Varicella Zoster Virus And Methods Of Use Thereof
US Patent:
2008027, Nov 13, 2008
Filed:
Sep 24, 2007
Appl. No.:
11/903708
Inventors:
Michael D. Gershon - New York NY, US
Zhenglun Zhu - Allston MA, US
Saul Silverstein - Irvington NY, US
Anne A. Gershon - New York NY, US
Zhenglun Zhu - Allston MA, US
Saul Silverstein - Irvington NY, US
Anne A. Gershon - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61K 39/12, C12N 7/00, C12Q 1/70
US Classification:
4242041, 4352351, 435 5
Abstract:
The present invention provides genetically engineered cell lines, recombinant vectors, and vaccines. The present invention also provides methods for generating an in vitro system for virus (VZV), and the in vitro systems generated by these methods. The present invention further provides methods for reactivating VZV, and VZV reactivated by these methods. Finally, the present invention provides a method of screening for an agent for treating VZV infection.
Treatment Of Development-Related Disorders
US Patent:
2013028, Oct 24, 2013
Filed:
Apr 9, 2013
Appl. No.:
13/859285
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
C12Q 1/68
US Classification:
4241391, 435 612, 514 44 A
Abstract:
Disclosed are composition and methods for treating development-related disorders. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.
Treatment And Diagnosis Of Immune Disorders
US Patent:
2012018, Jul 19, 2012
Filed:
Jul 15, 2010
Appl. No.:
13/382641
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
A61K 39/395, A61K 31/573, A61K 31/7088, A61K 31/52, A61K 31/519, G01N 21/64, A61P 29/00, A61P 11/00, A61K 38/17, C07K 14/47, C07K 16/18, C12Q 1/68, C07H 21/04, A61K 31/5377
US Classification:
4241391, 536 245, 514179, 514 44 A, 5142632, 514250, 5142335, 514 212, 514 44 R, 514 213, 536 2431, 536 2433, 530350, 5303879, 435 612, 436501
Abstract:
Disclosed are composition and methods for treating immune disorders. Also disclosed are diagnosis methods and prognosis methods.
Expanding Hematopoietic Stem Cells
US Patent:
2012016, Jun 28, 2012
Filed:
Nov 23, 2011
Appl. No.:
13/303675
Inventors:
Hong Gao - Allston MA, US
Zhenglun Zhu - Allston MA, US
Zhenglun Zhu - Allston MA, US
International Classification:
A61K 35/12, A61K 35/28, A61P 7/00, C12Q 1/68, A61P 43/00, A61P 7/06, C12N 5/0789, A61K 35/14
US Classification:
424 937, 435375, 435 612, 435 61
Abstract:
A method of expanding hematopoietic stem cells. Also disclosed is a method of diagnosing primary or secondary bone marrow failure syndrome. The invention further includes a method of treating primary or secondary bone marrow failure syndrome.
Treatment Of Development-Related Disorders
US Patent:
2011030, Dec 8, 2011
Filed:
Aug 9, 2011
Appl. No.:
13/206003
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
C12Q 1/68
US Classification:
435 612, 435 614
Abstract:
Disclosed are composition and methods for treating development-related disorders. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.